IRWD
Ironwood Pharmaceuticals, Inc. Healthcare - Drug Manufacturers - Specialty & Generic Investor Relations →
Ironwood Pharmaceuticals, Inc. (IRWD) closed at $4.56 as of 2026-02-02, trading 37.6% below its 200-week moving average of $7.31. This places IRWD in the extreme value zone. The stock is currently moving closer to the line, down from -33.5% last week. With a 14-week RSI of 75, IRWD is in overbought territory.
Over the past 787 weeks of data, IRWD has crossed below its 200-week moving average 25 times. On average, these episodes lasted 18 weeks. Historically, investors who bought IRWD at the start of these episodes saw an average one-year return of +5.1%.
With a market cap of $742 million, IRWD is a small-cap stock. The company generates a free cash flow yield of 5.3%, which is healthy. The stock trades at -2.8x book value.
Over the past 15.2 years, a hypothetical investment of $100 in IRWD would have grown to $48, compared to $702 for the S&P 500. IRWD has returned -4.7% annualized vs 13.7% for the index, underperforming the broader market over this period.
Free cash flow has been declining at a -26.6% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Growth of $100: IRWD vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After IRWD Crosses Below the Line?
Across 25 historical episodes, buying IRWD when it crossed below its 200-week moving average produced an average return of +1.3% after 12 months (median +1.0%), compared to +13.2% for the S&P 500 over the same periods. 52% of those episodes were profitable after one year. After 24 months, the average return was -5.4% vs +30.1% for the index.
Each line shows $100 invested at the moment IRWD crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
IRWD has crossed below its 200-week MA 25 times with an average 1-year return of +5.1% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jan 2011 | Feb 2011 | 4 | 5.0% | +6.8% | -51.9% |
| Aug 2011 | Oct 2011 | 11 | 13.7% | -7.5% | -56.3% |
| Nov 2011 | Jan 2012 | 10 | 13.3% | -0.8% | -55.0% |
| Apr 2012 | Jun 2012 | 8 | 10.4% | +43.7% | -56.0% |
| Jul 2012 | Sep 2012 | 6 | 8.6% | +0.6% | -56.5% |
| Oct 2012 | Jan 2013 | 12 | 17.2% | -15.3% | -56.9% |
| May 2013 | May 2013 | 1 | 0.3% | +8.4% | -57.6% |
| Jun 2013 | Sep 2013 | 12 | 22.7% | +24.7% | -53.7% |
| Sep 2013 | Jan 2014 | 16 | 27.2% | +4.1% | -55.0% |
| Feb 2014 | Feb 2014 | 1 | 0.3% | +27.0% | -56.8% |
| Mar 2014 | May 2014 | 6 | 22.2% | +30.9% | -54.5% |
| Aug 2014 | Aug 2014 | 1 | 5.9% | -10.0% | -55.3% |
| Sep 2014 | Oct 2014 | 5 | 7.9% | -7.5% | -56.8% |
| Jun 2015 | May 2016 | 51 | 35.1% | +6.0% | -55.2% |
| Jun 2016 | Jun 2016 | 2 | 4.0% | +40.2% | -56.6% |
| Jan 2018 | Feb 2018 | 2 | 3.0% | -0.7% | -59.9% |
| Oct 2018 | Dec 2019 | 57 | 36.3% | -12.2% | -61.4% |
| Jan 2020 | Jun 2021 | 74 | 27.0% | -16.4% | -63.1% |
| Nov 2021 | Jan 2022 | 7 | 6.4% | -0.5% | -61.0% |
| Jan 2022 | Mar 2022 | 7 | 8.0% | +3.8% | -58.5% |
| May 2022 | Jun 2022 | 3 | 0.6% | -8.1% | -60.0% |
| Aug 2022 | Oct 2022 | 10 | 9.5% | -17.1% | -59.1% |
| Feb 2023 | Feb 2023 | 1 | 0.3% | +37.2% | -59.2% |
| Mar 2023 | Dec 2023 | 40 | 26.8% | -15.6% | -57.3% |
| Feb 2024 | Ongoing | 102+ | 93.8% | Ongoing | -49.7% |
| Average | 18 | — | +5.1% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02